Skip to main content
. Author manuscript; available in PMC: 2020 May 14.
Published in final edited form as: Lab Chip. 2019 May 14;19(10):1877–1886. doi: 10.1039/c8lc01279b

Fig. 6.

Fig. 6

a) Illustration of ex vivo testing of surface-engineered exosomes for activating transgenic mice spleen-derived CD8+ T cells. b) depicts representative flow plots from wells containing T cells + Activated JAWS cells with increasing concentrations of the gp100-engineered exosomes. c) depicts the cumulative data from all three culture conditions showing the CD8+ T cell dividing rate under stimulation. The results are representative of 2 independent experiments with three duplicate wells for each culture condition (RSD < ~ 5%).